The Journal of Organic Chemistry
Article
CDCl ) δ 130.4, 121.2, 65.2, 60.6, 57.7, 56.0, 34.5, 31.6, 28.6, 26.5,
pentane/CH Cl , 5/1 to 3/1 to 1/1, p-anisaldehyde) to give (+)-11
3
2
2
2
9
2.5, 14.0; IR (thin film) 2956, 2928, 2858, 1463, 1455, 1250, 981,
(27 mg, 73%, R = 0.25 in 3/1, >20:1 dr) as a colorless oil and S 2′
f
N
−
1
34, 783, 668, 597 cm ; HRMS (CI-TOF) m/z calcd for
product 82 (9.6 mg, 26%, R = 0.33 and 0.24 in 1/1, 6:4 dr) as a
f
35
20
+
25
1
C H Cl ONH [M + NH ] 268.1235, found 268.1236.
colorless oil. Data for (+)-11: [α]D = +62.5 (c 1.00, CHCl ); H
12
2
4
4
3
(
−)-(3S,4S,5S,6R)-5,6-Dichloro-3,4-epoxy-1-dodecene (30),
NMR (600 MHz, CDCl ) δ 5.73 (app t, J = 10.3, 10.3 Hz, 1H), 5.66
3
(
−)-(3S,4R,5R,6S)-3,5,6-trichloro-1-dodecen-4-ol (35): To a stirred
(app dt, J = 10.7, 7.4, 7.4 Hz, 1H), 5.38 (dd, J = 9.9, 1.7 Hz, 1H), 4.49
(app dt, J = 10.3, 2.9, 2.9 Hz, 1H), 4.29 (dd, J = 9.0, 3.1 Hz, 1H), 3.92
(s, 2H), 3.83−3.78 (m, 1H), 2.34 (d, J = 10.5 Hz, 1H), 2.21−2.09 (m,
4H), 1.91−1.83 (m, 1H), 1.83−1.76 (m, 1H), 1.67−1.62 (m, 1H),
1.61−1.56 (m, 2H), 1.46−1.36 (m, 3H), 1.36−1.25 (m, 14H), 0.91 (s,
solution of (±)-30 (126 mg, 0.502 mmol) and (S,S)-41 (84 mg, 0.10
mmol) in CH Cl (2.5 mL) were added i-Pr NEt (9 μL, 0.05 mmol)
2
2
2
and SiCl (57 μL, 0.50 mmol) at −78 °C. After 24 h, a solution of
4
CH OH/Et N/CH Cl (1/1/5, 4 mL) was added quickly at −78 °C.
3
3
2
2
1
3
The resulting solution was vigorously stirred with a saturated aqueous
9H), 0.89 (app t, J = 6.8, 6.8 Hz, 3H), 0.11 (s, 6H); C NMR (126
NaHCO solution (20 mL) at rt for 2 h prior to filtration. The organic
layer was separated, and the aqueous layer was extracted with CH Cl2
10 mL). The combined organic extracts were dried over Na SO ,
filtered, and concentrated in vacuo (25 mmHg). (S,S)-41 was
recovered from the residue by column chromatography (SiO , ϕ =
.2 cm, l = 7 cm, CH Cl /i-PrOH, 10/1, R = 0.37, UV). The fractions
that contained 30 and 35 were combined and purified by column
chromatography (SiO , ϕ = 2.2 cm, l = 11 cm, n-pentane/CH Cl , 8/1
MHz, CDCl ) δ 135.7, 125.8, 93.5, 75.1, 66.8, 62.4, 60.1, 43.5, 32.5,
3
3
2
31.6, 29.3, 29.2, 29.1, 29.0 (2C), 28.6, 27.6, 26.5, 25.7, 24.7, 22.6, 18.3,
1
(
14.0, −5.4. Data for 82 (a 6:4 mixture of diastereomers): H NMR
2
4
(600 MHz, CDCl ) δ 5.97−5.90 (m, 1H), 5.79 (ddd, J = 15.2, 13.9,
3
2
6.8, 1H), 4.77 (app td, J = 7.3, 7.3, 3.9 Hz, 0.4H), 4.72 (app td, J = 7.2,
7.2, 4.3 Hz, 0.6H), 4.39 (app quintet, J = 7.4, 7.4, 7.4, 7.4 Hz, 1H),
4.18 (ddd, J = 8.8, 6.7, 4.1 Hz, 1H), 3.92 (s, 2H), 3.91−3.88 (m, 1H),
2.20−2.14 (m, 2H), 2.13−2.04 (m, 2H), 1.89−1.73 (m, 3H), 1.65−
1.51 (m, 3H), 1.50−1.37 (m, 3H), 1.37−1.23 (m, 14H), 0.91 (s, 9H),
0.89 (app t, J = 6.8, 6.8 Hz, 3H), 0.11 (s, 6H); 13C NMR (126 MHz,
2
2 2 f
2
2
2
to 4/1, p-anisaldehyde) to give (−)-35 (70 mg, 49%, R = 0.12 in 8/1,
f
8
8.1:11.9 er) as a colorless oil and (−)-30 as a colorless oil, which was
purified again by column chromatography (54 mg, 43%, R = 0.30 in
CDCl ) δ 136.0, 135.7, 128.22, 128.17, 93.5, 72.1, 72.0, 71.7, 69.4,
f
3
26
8
/1, 2.7:97.3 er). Data for (−)-30: [α] = −29.9 (c 1.00, CHCl );
GC (B-DM, 30 psi, 145 °C) t 15.5 min (2.7%), 16.5 min (97.3%).
Data for (−)-35: [α] = −60.6 (c 1.00, CHCl ); GC (B-DM, 30 psi,
65 °C) t 18.5 min (88.1%), 19.1 min (11.9%); H NMR (500 MHz,
CDCl ) δ 6.03 (ddd, J = 16.9, 10.2, 7.7 Hz, 1H), 5.49 (d, J = 16.9 Hz,
H), 5.35 (d, J = 10.2 Hz, 1H), 5.07 (d, J = 7.6 Hz, 1H), 4.51 (app dt,
69.1, 61.9, 61.7, 61.6, 43.5, 38.4, 38.3, 34.7, 34.5, 31.6, 29.30, 29.26,
29.0, 28.9, 28.61, 28.60, 26.43, 26.35, 25.7, 25.3, 25.2, 24.7, 22.5, 18.3,
14.1, −5.4; IR (thin film) 3403, 2929, 2857, 1463, 1256, 1153, 1120,
D
3
R
25
D
3
1
−1
1
970, 840, 780 cm .; HRMS (ESI-TOF) m/z calcd for
R
3
5
+
3
C H Cl O SiNa [M + Na] 647.2155, found 647.2143.
28 53 5 2
1
(−)-(11S,12R,13S,14R,15S,16R)-1-tert-Butyldimethylsiloxy-2,2,-
6b
J = 10.5, 2.7, 2.7 Hz, 1H), 4.31 (dd, J = 9.4, 2.7 Hz, 1H), 3.89 (app td,
J = 9.8, 9.8, 1.3 Hz, 1H), 2.23 (d, J = 9.9 Hz, 1H), 1.92−1.83 (m, 1H),
11,13,15,16-hexachloro-14-hydroxy-12-iododocosane (83): To
a stirred solution of (+)-11 (27 mg, 0.043 mmol) and imidazole (8.8
1
(
1
.83−1.74 (m, 1H), 1.68−1.58 (m, 1H), 1.46−1.23 (m, 7H), 0.89
mg, 0.13 mmol) in CH
mmol) at rt. After being stirred for 10 min, the reaction mixture was
cooled to −78 °C and ICl (1.0 M in CH Cl , 215 μL, 0.215 mmol)
was added. After being stirred for 20 min at −78 °C, a solution of CSA
(100 mg, 0.43 mmol) in CH OH (645 μL) was added and the cold
bath was removed. After being stirred for 30 min, the brown solution
was poured into a stirred mixture of saturated aqueous NaHCO
solution (5 mL) and saturated aqueous Na S O solution (5 mL). The
2 2
Cl (430 μL) was added TMSCl (11 μL, 0.086
app t, J = 6.6, 6.6 Hz, 3H); 13C NMR (126 MHz, CDCl ) δ 134.4,
3
19.6, 74.5, 66.5, 65.0, 62.5, 32.4, 31.6, 28.6, 26.5, 22.6, 14.0; IR (thin
2
2
film) 3540, 2956, 2927, 2857, 1465, 1379, 1265, 1096, 1069, 987, 935
−
1
35
cm ; HRMS (CI-TOF) m/z calcd for C H Cl ONH4 [M +
3
12
21
3
+
NH ] 304.1002, found 304.1000.
4
(
+)-(11Z,13S,14S,15S,16R)-1-tert-Butyldimethylsiloxy-2,2,-
3
6
b
1
5,16-tetrachloro-13,14-epoxy-11-docosene (10): The solvents
2
2
3
were bubbled with argon for 15 min before use. To a stirred solution
resulting colorless biphasic mixture was diluted with CH Cl (10 mL)
2 2
of (−)-30 (52 mg, 0.21 mmol) and 71 (152 mg, 0.414 mmol) in DCE
and H O (10 mL). The organic layer was separated, and the aqueous
2
(
(
1
210 μL) in a test tube (12 mm × 75 mm) was added a solution of 60
layer was extracted with CH Cl (10 mL × 2). The combined organic
2
2
39 mg, 0.062 mmol) in CH Cl (210 μL) in three portions (0, 0.5,
extracts were washed with saturated aqueous NH Cl solution (20 mL),
2
2
4
.0 h) at 35 °C while the reaction mixture was vigorously bubbled with
and the aqueous layer was extracted with CH Cl (10 mL × 2). The
2
2
33
argon (saturated with DCE). After being stirred at 35 °C with argon
bubbling for an additional 2 h, the reaction mixture was cooled to rt,
filtered through silica gel (ϕ = 2.2 cm, l = 9 cm, CH Cl , 40 mL), and
combined organic extracts were dried over Na SO , filtered, and
2 4
concentrated in vacuo (25 mmHg). The residue was purified by
2
2
column chromatography (SiO , ϕ = 1.1 cm, l = 5.5 cm, n-pentane/
2
concentrated in vacuo (25 mmHg). The residue was purified by
CH Cl , 5/1 to 3/1, R = 0.29 in 3/1, p-anisaldehyde) to give (−)-83
2
2
f
2
6
column chromatography (SiO , ϕ = 3.8 cm, l = 15 cm, n-pentane/
(28 mg, 82%, 95:5 dr) as a colorless oil. Data for (−)-83: [α]
=
2
D
1
CH Cl , 8/1, R = 0.24, p-anisaldehyde) to give (+)-10 (35 mg, 29%,
−7.6 (c 1.00, CHCl ); H NMR (600 MHz, CDCl ) δ 4.98 (d, J =
2
2
f
3
3
2
6
>
20:1 = Z:E) as a colorless oil. Data for (+)-10: [α]D = +14.2 (c
.00, CHCl ); H NMR (600 MHz, CDCl ) δ 5.86 (app dt, J = 10.9,
.6 Hz, 7.6, 1H), 5.26−5.20 (m, 1H), 4.21 (ddd, J = 9.6, 4.4, 4.0 Hz,
H), 3.92 (s, 2H), 3.76 (dd, J = 9.1, 4.0 Hz, 1H), 3.74 (dd, J = 7.9, 4.3
10.9 Hz, 1H), 4.72 (app t, J = 10.6, 10.6 Hz, 1H), 4.56 (dd, J = 10.9,
1.8 Hz, 1H), 4.48 (app dt, J = 10.5, 2.6, 2.6 Hz, 1H), 4.38 (dd, J = 9.8,
2.4 Hz, 1H), 3.92 (s, 2H), 3.75−3.71 (m, 1H), 2.19−2.16 (m, 2H),
2.14 (d, J = 11.3 Hz, 1H), 2.04−1.97 (m, 1H), 1.97−1.88 (m, 1H),
1.83−1.78 (m, 1H), 1.77−1.71 (m, 1H), 1.69−1.62 (m, 1H), 1.62−
1.56 (m, 2H), 1.53−1.46 (m, 1H), 1.46−1.38 (m, 3H), 1.38−1.27 (m,
1
1
7
1
3
3
Hz, 1H), 3.44 (dd, J = 9.1, 4.2 Hz, 1H), 2.27−2.19 (m, 2H), 2.19−
2
3
3
7
2
.14 (m, 2H), 1.99−1.86 (m, 2H), 1.66−1.55 (m, 3H), 1.46−1.39 (m,
1
3
H), 1.39−1.26 (m, 14H), 0.91 (s, 9H), 0.89 (app t, J = 6.9, 6.9 Hz,
13H), 0.92 (s, 9H), 0.90 (app t, J = 6.8, 6.8 Hz, 3H), 0.11 (s, 6H);
C
1
3
H), 0.11 (s, 6H); C NMR (126 MHz, CDCl ) δ 139.6, 121.5, 93.5,
NMR (126 MHz, CDCl ) δ 93.5, 74.6, 72.1, 66.3, 66.0, 62.9, 62.8,
3
3
2.1, 65.2, 61.5, 57.4, 52.5, 43.5, 34.3, 31.6, 29.29, 29.27, 29.26, 29.1,
43.5, 42.6, 40.6, 32.8, 31.6, 29.2 (2C), 29.0, 28.9, 28.6, 26.6, 26.2, 25.7,
9.0, 28.6, 28.1, 26.5, 25.7, 24.7, 22.5, 18.3, 14.0, −5.4.
24.7, 22.6, 18.3, 14.1, −5.3.
(
+)-(7R,8S,9S,10R,11Z)-22-tert-Butyldimethylsiloxy-7,8,10,21,-
(+)-(11S,13S,14R,15S,16R)-1-tert-Butyldimethylsiloxy-2,2,-
6
b
6b
2
1-pentachloro-11-docosen-9-ol (11): To a stirred solution of
11,13,15,16-hexachloro-14-hydroxydocosane (84): Toluene was
(
+)-10 (35 mg, 0.059 mmol) and Et NCl (30 mg, 0.18 mmol) in
bubbled with argon for 20 min before use. To a stirred solution of
4
CH Cl (240 μL) was added BF ·OEt (15 μL, 0.12 mmol) at −78 °C.
(−)-83 (28 mg, 0.035 mmol) in toluene (355 μL) were added n-
3 6 6
2
2
3
2
1
34
After being stirred for 1 h, the reaction mixture was poured into an ice-
Bu SnH (11 μL, 0.041 mmol, 99% pure by H NMR in C D ) and
cold saturated aqueous NaHCO solution (10 mL). To the biphasic
Et B (1.0 M in THF, 7 μL, 0.007 mmol) at −78 °C. After being stirred
3
3
mixture were added CH Cl (10 mL) and H O (10 mL). The organic
for 2 h at −78 °C, n-pentane (3.55 mL) was added and the resulting
2
2
2
layer was separated, and the aqueous layer was extracted with CH Cl2
solution was concentrated in vacuo (25 mmHg). The residue was
2
(
10 mL × 2). The combined organic extracts were dried over Na SO ,
purified by column chromatography (SiO , ϕ = 1.1 cm, l = 5.5 cm, n-
2
4
2
filtered, and concentrated in vacuo (25 mmHg). The residue was
purified by column chromatography (SiO , ϕ = 1.5 cm, l = 9 cm, n-
pentane/CH Cl , 1/0 to 4/1, R = 0.25 in 4/1, p-anisaldehyde) to give
2
2
f
2
5
(+)-84 (21.5 mg, 91%) as a colorless oil. Data for (+)-84: [α]D =
2
L
dx.doi.org/10.1021/jo5000829 | J. Org. Chem. XXXX, XXX, XXX−XXX